This website is intended for healthcare professionals

02 May 2017

Volume 25 | Issue 5

ISSN (Print): 0969-4900

ISSN (Online): 2052-4307

Randomised controlled trials

In December 2005, Professor (now Sir) Ian Wilmut, the first director of Edinburgh University's Centre for Regenerative Medicine, called for stem cell treatments to be offered to people with terminal illnesses He argued that the benefits of offering such treatments before they had been properly evaluated might outweigh the risks, saying, ‘if we wait until things are totally tested and analysed in animals, it will deny some people treatment’ (BBC News, 2005)

More from this issue